Afuco™ Anti-HCMV ADCC Therapeutic Antibody (Regavirumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human cytomegalovirus glycoprotein B. Regavirumab is a human monoclonal antibody against cytomegalovirus infections.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-894 |
| Pricing | Inquiry |
| Host | Human |
| Target | HCMV |
| Species Reactivity | HHV-5 |
| Type | ADCC enhanced antibody |
| Applications | FuncS, IF, Neut, ELISA, FC, IP |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |